• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SUNEVA MEDICAL, INC. BELLAFILL DERMAL FILLER; IMPLANT, DERMAL, FOR AESTHETIC USE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SUNEVA MEDICAL, INC. BELLAFILL DERMAL FILLER; IMPLANT, DERMAL, FOR AESTHETIC USE Back to Search Results
Model Number GBF0508 (SUSPECTED)
Device Problems Off-Label Use (1494); Improper or Incorrect Procedure or Method (2017)
Patient Problems Post Operative Wound Infection (2446); Patient Problem/Medical Problem (2688)
Event Date 01/01/2014
Event Type  Injury  
Manufacturer Narrative
The account reported on 2019-06-25 that the patient was injected with bellafill dermal filler about 5-6 years ago (date unknown) in multiple off-label locations (nose, forehead, eyebrows, chin, jawline) and developed an infection in the nose at the time of injection, which required treatment to resolve.They prescribed antibiotics and the infection resolved at that time.There were no other infections reported in the other areas injected at the same time as the nose.Notes: it was also reported on 2019-06-25 that the patient has some current redness and warmth in the nose area, but was not noted by the doctor to be a concern.The patient is also reported to have suspected granuloma which began presenting about a year ago in all areas of injection (nose, forehead, eyebrows, chin, jawline).There is no indication at this time that medical intervention is required to resolve the suspected granuloma.Granuloma is an anticipated patient event that is documented in the bellafill instructions for use.Clinical studies support that granuloma may resolve over time with or without treatment.The lot numbers are unknown at this time.The injection files had been archived by the account.The date of injection is unknown at this time; therefore potential lot numbers cannot be determined and bellafill dermal filler use is not confirmed.The infection in the nose resolved after treatment with antibiotics, after the dermal filler injections ~5-6 years ago, and no further information is available regarding the infection.The suspected root cause is off-label use.Per the bellafill instructions for use: bellafill dermal filler is indicated for the correction of nasolabial folds and moderate to severe, atrophic, distensible facial acne scars on the cheek in patients over the age of 21 years.The instructions for use also contains the precaution: as with all transcutaneous procedures, bellafill injection carries a risk of infection.The usual precautions associated with injectable materials should be followed.Bellafill syringes are single use devices and are typically discarded after use.Per the bellafill ifu: "the syringe and any unused material should be discarded after a single treatment visit.".
 
Event Description
Account reported that the patient was injected with bellafill dermal filler about 5-6 years ago (date unknown) in multiple off-label locations (nose, forehead, eyebrows, chin, jawline) and developed an infection in the nose at that time, which required treatment to resolve.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BELLAFILL DERMAL FILLER
Type of Device
IMPLANT, DERMAL, FOR AESTHETIC USE
Manufacturer (Section D)
SUNEVA MEDICAL, INC.
5870 pacific center blvd.
san diego CA 92121
Manufacturer (Section G)
SUNEVA MEDICAL, INC.
5870 pacific center blvd.
san diego CA 92121
Manufacturer Contact
stacy lewis
5870 pacific center blvd.
san diego, CA 92121
8587685492
MDR Report Key8829047
MDR Text Key152465949
Report Number3003707320-2019-00008
Device Sequence Number1
Product Code LMH
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P020012
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 07/25/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/25/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberGBF0508 (SUSPECTED)
Device Catalogue NumberGBF0508 (SUSPECTED)
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/25/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-